Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
204
datasets available to search
ShareScore release 0.9.0
Dataset results
204 results for “chronic migraine”
Laser Acupuncture for Chronic Migraine
ClinicalTrials.gov study NCT06219694. IPD Sharing: NO. Countries: 1. Publications: 0.
Biofeedback-VR for Treatment of Chronic Migraine
ClinicalTrials.gov study NCT05720819. IPD Sharing: NO. Countries: 1. Publications: 0.
Bilateral Embolization of the Middle Meningeal Arteries for Refractory Chronic Migraine
ClinicalTrials.gov study NCT07223008. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of MIGRA-ZEN RELIEF PLUS In the Treatment of Chronic Migraine Headache
ClinicalTrials.gov study NCT01135784. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Effects of tDCS and Physical Therapy in Chronic Migraine
ClinicalTrials.gov study NCT05706077. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Mind Body Intervention for Chronic Migraine Headaches
ClinicalTrials.gov study NCT06690060. IPD Sharing: NO. Countries: 1. Publications: 0.
Effect of Treatment of Temporomandibular Joint in Patients With Chronic Migraine and Temporomandibular Disorders
ClinicalTrials.gov study NCT02627014. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Trip-Tox, Effectiveness of Triptans Before and After Onabotulinumtoxin A Treatment in Chronic Migraine
ClinicalTrials.gov study NCT04871152. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Digital CBTI for Comorbid Insomnia in Chronic Migraine
ClinicalTrials.gov study NCT05244889. IPD Sharing: YES. Countries: 1. Publications: 0.
Presence of Signs of Central Sensitization in Episodic and Chronic Migraine
ClinicalTrials.gov study NCT05162664. IPD Sharing: NO. Countries: 1. Publications: 0.
TI-001 (Intranasal Oxytocin) for Treatment of High Frequency Episodic Migraine and Chronic Migraine
ClinicalTrials.gov study NCT01839149. IPD Sharing: Not stated. Countries: 3. Publications: 0.
A Study With Eptinezumab in Adolescents (12-17 Years) With Chronic Migraine
ClinicalTrials.gov study NCT04965675. IPD Sharing: Not stated. Countries: 11. Publications: 0.
Bilateral Middle Meningeal Artery Lidocaine Infusion for Chronic Debilitating Migraines
ClinicalTrials.gov study NCT07061847. IPD Sharing: NO. Countries: 1. Publications: 0.
Sphenopalatine Block Versus BOTOX in Management of Chronic Migraine
ClinicalTrials.gov study NCT06974617. IPD Sharing: YES. Countries: 1. Publications: 0.
Chronic Migraine Treatment With Botulinum Toxin-A: an Investigation of Functional Magnetic Resonance Imaging Changes.
ClinicalTrials.gov study NCT02436499. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Supplemental material for: PROMISE-2: Efficacy and safety of eptinezumab in patients with chronic migraine
Open the record for dataset details and reuse information.
Offset analgesia as a marker of dysfunctional pain modulation in episodic and chronic migraine
<p>In the database the following data are reported: warm detection threshold (EDT), heat pain threshold (HPT), visual analogue scale (VAS) values recorded during the constant trial (CT) and the offset analgesia trial (OT) in healthy volunteers, in subjects with episodic migraine during the different phases of the migraine cycle (interictal, preictal, ictal, postictal), and in subjects with chronic migraine with or without medication overuse. Demographic and clinical variables are also reported including:<span> </span>disease duration, predominant headache side, presence of aura symptoms, mean headache intensity during a migraine attack, mean attack duration, mean number of days with mild or moderate-to-severe intensity headache over the last three months, mean number of symptomatic medications taken in the last three months, mean number of days in which symptomatic medications have been taken in the last three months, scores at the following questionnaires: 12-item Allodynia Symptom Checklist (ASC-12), Migraine Disability Assessment (MIDAS), and Hospital Anxiety and Depression Scale (HADS).</p>
A Retrospective Study to Evaluate the Effectiveness of onabotulinumtoxinA in Preventing Headaches in Patients With Chronic Migraines
ClinicalTrials.gov study NCT01749423. IPD Sharing: Not stated. Countries: 0. Publications: 0.
TCDS for the Treatment of Chronic Migraine
ClinicalTrials.gov study NCT07214454. IPD Sharing: YES. Countries: 0. Publications: 0.
An Open Label Extension of a Study of Topiramate in Chronic Migraine.
ClinicalTrials.gov study NCT00210873. IPD Sharing: Not stated. Countries: 0. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.